Investor FAQs

Show All

Heartflow is a commercial-stage medical technology company that has pioneered the use of software and AI to deliver a more accurate and clinically effective non-invasive solution for diagnosing and managing coronary artery disease (“CAD”), a leading cause of death worldwide. We believe that we are the most widely adopted AI-powered test for CAD. Our novel Heartflow Platform leverages AI and advanced computational fluid dynamics to create a personalized 3D model of a patient’s heart from a single coronary computed tomography angiography (“CCTA”), a specialized type of scan that provides detailed images of the heart’s arteries. The Heartflow Platform delivers actionable insights on blood flow, stenosis, plaque volume and plaque composition, thereby overcoming the limitations of traditional non-invasive imaging tests which rely on indirect measures of coronary disease and lead to higher false negative and false positive rates.

Our principal executive offices are located at 135 Main St. Suite 1000, San Francisco, CA 94105

Our ticker is HTFL and it is traded on the NASDAQ exchange.

Heartflow does not currently have a direct stock purchase plan.

Quarterly and annual reports, as well as other SEC filings, can be accessed on the SEC Filings portion of our Investor Relations website or directly from the SEC at www.sec.gov.

Our fiscal year end is December 31.

We do not intend to pay cash dividends on our common stock, as we intend to retain all available funds and any future earnings to support operations and finance the growth and development of our business.

Our independent registered public accountants are PricewaterhouseCoopers LLP.

Fidelity Stock Transfer℠ (FST) is our transfer agent and registrar. You may contact FST with any questions about your share ownership through any of the methods listed here:

Phone: (Toll-Free)
(833) 500-1036

Representatives are available to assist you by phone from 8:00 a.m. to 8:00 p.m. EST, Monday through Friday.

Email
FSTOperations@fmr.com

Mail
Fidelity Investments
Attn: Fidelity Stock Transfer Solutions
PO Box 770017
Cincinnati, OH 45277

Overnight Mail
Fidelity Investments
Attn: Fidelity Stock Transfer Solutions
100 Crosby Parkway
Mail Zone KY16
Covington, KY 41015

You can view our management team and members of our Board of Directors by visiting the Management Team section of our website.

We will issue press releases that include the date of our quarterly earnings calls periodically. When the release is issued, call details and webcast links will be posted on the Events section of our website.

You can view our latest press releases, including our quarterly financial releases, on the News Releases section of our website.

You can contact Heartflow's Investor Relations via email at: IR@heartflow.com.

Fidelity Stock Transfer Solutions LLC
245 Summer Street
Boston, MA 02210

Investor Contact

Nick Laudico
Vice President, Investor Relations
nlaudico@heartflow.com

Subscribe to our email alerts